Drug Profile


Alternative Names: ING 1 antibody; ING-1

Latest Information Update: 16 Jul 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator XOMA
  • Class Antineoplastics; Monoclonal antibodies
  • Mechanism of Action Epithelial cell adhesion molecule inhibitors; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Adenocarcinoma

Most Recent Events

  • 03 Jun 2008 Oncologic Inc has merged with Triton BioSystems to form Aduro BioTech
  • 09 May 2005 ING 1 is available for licensing outside the field covered by the Triton BioSystems license (
  • 08 Oct 2004 ING 1 has been licensed to Triton BioSystems worldwide
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top